Clinical Trial Update: A Phase II Trial of LM103 in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase II clinical trial of LM103 for melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• LM103

Snippet

Sponsor: Suzhou BlueHorse Therapeutics Co., Ltd. | Conditions: Advanced Melanoma | Phase 2 | Status: RECRUITING